Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Experts call for EU ban on diclophenic
vulture
The paper blames diclophenac for the near-extinction of vultures in Pakistan, India and Nepal in the 1990s.

Research paper warns of the risks of veterinary pharmaceuticals to wildlife

Experts are calling for an EU-wide ban on the use of diclophenac in livestock, as it is placing fragile vulture populations at risk.

According to research published in the journal Science this week, a "one health" approach is needed to address the dangers of veterinary pharmaceuticals to wildlife.

Even traces of the drug in livestock carcasses are fatal to the vultures who feed on them. Contamination of less than 1 per cent of carcasses previously led to the near extinction of three Asian species. For this reason, veterinary use of diclophenac has already been banned in many South Asian countries.

Dr Lisa Yon from the University of Nottingham's School of Veterinary Medicine, said: "It is clear from the lessons learned on the profound impact of diclofenac on vultures in India that we need to take a more integrated, 'one Health' approach to our use of VPs, and the larger impact they have on non-target species, and on the environment. 

"This is and will continue to be an issue of increasing concern for a wide variety of VPs, and one for which there needs to be greater responsibility taken across the range of stakeholders."

Last year, diclophenac was authorised for use in cattle, pigs and horses in Spain, where more than 95 per cent of the continent's vultures reside.

Spanish vultures help to control pests and disease by removing more than 8,000 tonnes of livestock caresses each year. This is estimated to save the economy €1.5 million annually.

Lead author of the research was Thijs Kuiken, professor of Comparative Pathology at the Erasmus Medical Centre. He said he was "shocked" that the drug had been authorised in Spain. "This example shows that we need to radically change the way we deal with pharmaceuticals, both those used in human and veterinary medicine."

The paper, titled "One health approach to use of veterinary pharmaceuticals", blames diclophenac for the near-extinction of vultures in Pakistan, India and Nepal in the 1990s. Veterinary diclophenac products were banned in India in 2006 and Pakistan, Nepal and Bangladesh followed suit shortly after. Experts say vulture declines have slowed or reversed in South Asia since the ban.

Co-author Martin Gilbert, a Wildlife Conservation Society vet, said the loss of vultures in South Asia was a "tragedy". He warned that unless action is taken, the situation could occur in Europe.

For the full study, visit: http://www.sciencemag.org/content/early/2014/12/03/science.1260260

Image ©Wikipedia/CC BY-SA 2.5/Thermos

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.